BACKGROUND Studies of patients presenting for catheter ablation suggest that premature ventricular contractions
Baseline beta-blocker use was ascertained using an in-home medication inventory, and was defined as a current prescription filled by a pharmacist or physician, and taken by the patient in the previous 2 weeks (11).
EVENT ASCERTAINMENT. Medical records were obtained for all hospitalizations after study enrollment. Cox proportional hazards models incorporating log-transformed percentage of PVC counts were used to estimate the 15-year risk of CHF. Three models were examined: the first using PVC percentage alone; the second using baseline covariates as previously described; and the third using both the baseline covariates and PVC percentage. Predicted risks from the first model were plotted against the percentage of the PVC count, and sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for various percentage of PVC thresholds. Discrimination of each of the 3 models was assessed using the cross-validated C-index; biascorrected 95% bootstrap percentile CIs were used to assess differences in the C-index among the 3 models.
The population attributable risk for incident CHF was calculated for the following covariates using a counterfactual approach (12) Table 1 ).
Over 5 years, each doubling of the baseline PVC percentage was associated with a statistically significantly greater odds of a decrease in the LVEF in both the unadjusted and adjusted analyses (Central Illustration). Similar statistically significant associations were observed when PVC percentages were analyzed as quartiles ( Table 2 ). There was also a Figure 1 ). Both Holter-identified AF and VT were independently associated with incident CHF before and after multivariate adjustment (Online Table 3 ).
Sixty-nine (22%) of the incident CHF events were TEST CHARACTERISTICS. In the CHF prediction model using PVC percentage alone, the 15-year risk for CHF rose abruptly as the percentage of PVCs increased between 0% and 0.5%, with tapering of the risk curve for PVC percentages >10% (Figure 2) . The specificity for CHF prediction exceeded 90% when PVCs included at least 0.7% of total ventricular beats.
The PPV for the 15-year risk of incident CHF was >50% for PVC percentages between 1.24% and 3.55%.
Cross-validated C-indexes were 0.566 for the Cox model using PVC percentage alone, 0.587 for the model using baseline covariates alone, and 0.594 for the model using both. The 95% bootstrap CI for the CHF currently affects >5 million Americans, and its prevalence is expected to increase by 25% within the next 15 years (13) . Up to 50% of CHF cases have no Unadjusted Kaplan-Meier estimates depicting incident congestive heart failure (CHF) and mortality, as stratified by the percent of premature ventricular contraction (PVC) count quartiles. Quartiles 1 through 4 represent PVC burdens of 0% to 0.002%, 0.002% to 0.011%, 0.011% to 0.123%, and 0.123% to 17.7%, respectively. Consistent with the serial echocardiographic findings on all participants, the CHF events associated with increasing PVCs appeared to be primarily due to systolic dysfunction. The mechanism(s) by which frequent PVCs may lead to systolic dysfunction remains unknown; however, the available evidence favors adverse ventricular remodeling that occurs due to repeated dyssynchrony (24, 25) and impaired calcium handling (26) , rather than a tachycardiainduced cardiomyopathy (27) .
To characterize the potential clinical interpretation of these findings, we constructed test characteristics for varying PVC percentages using the 15-year risk of CHF as the reference outcome. Sensitivity was low, reflecting the fact that few patients who developed CHF had high PVC burdens. However, the specificity was quite high, >90% for PVCs that represented as little as 0.7% of the total ventricular beats and rising to >99% for PVC percentages $10%. The PPV was more clinically relevant; among those with 3% PVCs, more than one-half would go on to develop heart failure. In light of both the high specificity and PPV, patients with high PVC burdens might warrant special attention. These data also revealed a heightened CHF risk at a far lower PVC percentage than previously recognized (17, 19) . However, cross-validated C-indexes showed that the discrimination of all 3 of the prediction models was poor to moderate, at best.
Furthermore, adding the PVC percentage to the prediction model for CHF using clinically available variables did not achieve statistically significant increases in discrimination, although substantial increases of up to 5% could not be excluded. Further research might be indicated to investigate the prognostic utility of adding PVC burden to other established CHF prediction models. STUDY LIMITATIONS. Our participants were predominately elderly and white, which might constrain the generalizability of our results. We did not have data on particular PVC coupling intervals, PVC QRS durations, or PVC morphologies. We also did not examine baseline or interim differences in medication use, which might have biased our results in either direction. Finally, despite data from the electrophysiology laboratory that PVCs caused heart failure in some patients, and although we were confident of the association between antecedent PVCs and the development of CHF in our cohort, our observational study did not prove a causal relationship.
CONCLUSIONS

An increased percentage of PVCs detected by 24-h
Holter monitoring was associated with a subsequent decrease in the LVEF, increased incident CHF, and increased mortality. These effects were observed at a far lower PVC percentage than previously recognized. The relationship between increased PVCs and mortality appeared to be at least partly mediated by incident CHF. The specificity of PVCs for the longterm diagnosis of CHF was high, and the risk of incident CHF attributable to PVCs was comparable to that of other CHF risk factors. These findings suggest that PVC might be an important cause of occult or "idio- 
